perrhenate has been researched along with Pancreatic Neoplasms in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Aranđelović, S; Belaj, F; Gligorijević, N; Grgurić-Šipka, S; Mihajlović-Lalić, LE; Petrović, T; Poljarević, J | 1 |
| Behr, TM; Riese, CG; Schipper, ML; Seitz, S | 1 |
2 other study(ies) available for perrhenate and Pancreatic Neoplasms
| Article | Year |
|---|---|
Drug combination study of novel oxorhenium(V) complexes.
Topics: Adenocarcinoma; Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Cell Proliferation; Coordination Complexes; Drug Combinations; Humans; Pancreatic Neoplasms; Rhenium | 2022 |
Effective treatment of pancreatic neuroendocrine tumours transfected with the sodium iodide symporter gene by 186Re-perrhenate in mice.
Topics: Animals; Cell Line, Tumor; Humans; Mice; Neuroendocrine Tumors; Pancreatic Neoplasms; Radioisotopes; Rhenium; Symporters; Tissue Distribution; Transfection | 2009 |